Literature DB >> 30779592

High-Grade Sinonasal Carcinoma: Classification Through Molecular Profiling.

Julie Guilmette1, Peter M Sadow1.   

Abstract

High-grade sinonasal carcinomas are a cohort of malignant epithelial neoplasms arising in the sinonasal cavities with distinct, ominous morphologic features or lacking well-differentiated features that might otherwise classify them as less biologically worrisome. Recent advances in molecular profiling have led to the identification of several distinct tumor entities previously grouped together. These molecularly distinct lesions include NUT (midline) carcinoma, INI1 (SMARCB1)-deficient carcinoma, SMARCA4-deficient sinonasal carcinoma, and novel IDH-mutant sinonasal undifferentiated carcinoma, in addition to the previously described lymphoepithelial carcinoma that may also be included in the differential diagnosis. The discovery of these distinct molecular tumor profiles may have significant clinical impact as targeted molecular-based therapeutics continue to evolve, and they may offer some respite for patients who have these highly aggressive cancers.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30779592      PMCID: PMC7405598          DOI: 10.5858/arpa.2018-0224-RS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  23 in total

1.  SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.

Authors:  Abbas Agaimy; Arndt Hartmann; Cristina R Antonescu; Simion I Chiosea; Samir K El-Mofty; Helene Geddert; Heinrich Iro; James S Lewis; Bruno Märkl; Stacey E Mills; Marc-Oliver Riener; Thomas Robertson; Ann Sandison; Sabine Semrau; Roderick H W Simpson; Edward Stelow; William H Westra; Justin A Bishop
Journal:  Am J Surg Pathol       Date:  2017-04       Impact factor: 6.394

Review 2.  Meta-analysis of treatment outcomes for sinonasal undifferentiated carcinoma.

Authors:  David A Reiersen; M Elaine Pahilan; Anand K Devaiah
Journal:  Otolaryngol Head Neck Surg       Date:  2012-03-29       Impact factor: 3.497

3.  Sinonasal undifferentiated carcinoma and nasopharyngeal-type undifferentiated carcinoma: two clinically, biologically, and histopathologically distinct entities.

Authors:  Yung-Ming Jeng; Ming-Tse Sung; Chia-Lang Fang; Hsuan-Ying Huang; Tsui-Lien Mao; Wei Cheng; Cheng-Hsiang Hsiao
Journal:  Am J Surg Pathol       Date:  2002-03       Impact factor: 6.394

Review 4.  Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances.

Authors:  José Luis Llorente; Fernando López; Carlos Suárez; Mario A Hermsen
Journal:  Nat Rev Clin Oncol       Date:  2014-06-17       Impact factor: 66.675

Review 5.  The importance of diagnosing NUT midline carcinoma.

Authors:  Christopher A French
Journal:  Head Neck Pathol       Date:  2013-03-05

6.  Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma.

Authors:  Vickie Y Jo; Nicole G Chau; Jason L Hornick; Jeffrey F Krane; Lynette M Sholl
Journal:  Mod Pathol       Date:  2017-01-13       Impact factor: 8.209

7.  Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas.

Authors:  Snjezana Dogan; Deborah J Chute; Bin Xu; Ryan N Ptashkin; Raghu Chandramohan; Jacklyn Casanova-Murphy; Khedoudja Nafa; Justin A Bishop; Simion I Chiosea; Edward B Stelow; Ian Ganly; David G Pfister; Nora Katabi; Ronald A Ghossein; Michael F Berger
Journal:  J Pathol       Date:  2017-06-09       Impact factor: 9.883

8.  The mechanisms of IDH mutations in tumorigenesis.

Authors:  Dan Ye; Yue Xiong; Kun-Liang Guan
Journal:  Cell Res       Date:  2012-03-27       Impact factor: 46.297

9.  SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms.

Authors:  Abbas Agaimy; Michael Koch; Michael Lell; Sabine Semrau; Wojciech Dudek; David L Wachter; Antje Knöll; Heinrich Iro; Florian Haller; Arndt Hartmann
Journal:  Am J Surg Pathol       Date:  2014-09       Impact factor: 6.394

Review 10.  IDH mutations in cancer and progress toward development of targeted therapeutics.

Authors:  L Dang; K Yen; E C Attar
Journal:  Ann Oncol       Date:  2016-04       Impact factor: 51.769

View more
  4 in total

1.  SMARCB1 (INI-1)-Deficient Adenocarcinoma of the Sinonasal Tract: A Potentially Under-Recognized form of Sinonasal Adenocarcinoma with Occasional Yolk Sac Tumor-Like Features.

Authors:  Akeesha A Shah; Deepali Jain; Emad Ababneh; Abbas Agaimy; Aaron P Hoschar; Christopher C Griffith; Kelly R Magliocca; Bruce M Wenig; Lisa M Rooper; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2019-08-29

2.  Unclassified Neuroendocrine Tumor with a Novel CHD4::AFF2 Fusion: Expanding the Family of AFF2-Rearranged Head and Neck Malignancies.

Authors:  Daniel L Miller; Doreen N Palsgrove; Anu Rijal; Vivan Hathuc; Rebecca Chernock; Jeffrey Gagan; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2022-02-26

Review 3.  The implications of IDH mutations for cancer development and therapy.

Authors:  Christopher J Pirozzi; Hai Yan
Journal:  Nat Rev Clin Oncol       Date:  2021-06-15       Impact factor: 66.675

Review 4.  Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment.

Authors:  Mario Turri-Zanoni; Giacomo Gravante; Paolo Castelnuovo
Journal:  Curr Oncol Rep       Date:  2022-01-20       Impact factor: 5.075

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.